Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

Recent studies suggest that combining nivolumab with ipilimumab is a more effective treatment for melanoma patients, compared to using ipilimumab or nivolumab alone. However, treatment with these immunotherapeutic agents is frequently associated with increased risk of toxicity, and (auto-) immune-re...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel)
Main Authors: Soldatos, Theodoros G., Dimitrakopoulou-Strauss, Antonia, Larribere, Lionel, Hassel, Jessica C., Sachpekidis, Christos
Format: Artigo
Language:Inglês
Published: MDPI 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6316083/
https://ncbi.nlm.nih.gov/pubmed/30384507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics8040076
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items